Iridex (IRIX) EBT Margin Growth (3y) (2013 - 2026)
Iridex (IRIX) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 423.00 |
| 10 | Iridex | 13.32 Mn | 8.64 Mn | 4.30 Mn | 1,192.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,121.00 |
| Jan 3, 2026 | -4,330.00 |
| Sep 27, 2025 | -59.00 |
| Jun 28, 2025 | 900.00 |
| Mar 29, 2025 | 364.00 |
| Dec 28, 2024 | -978.00 |
| Sep 28, 2024 | -28.00 |
| Jun 29, 2024 | -3,149.00 |
| Mar 30, 2024 | -1,239.00 |
| Sep 30, 2023 | 585.00 |
| Jul 1, 2023 | 2,318.00 |
| Apr 1, 2023 | 306.00 |
| Dec 31, 2022 | 5,524.00 |
| Oct 1, 2022 | 469.00 |
| Jul 2, 2022 | 695.00 |
| Apr 2, 2022 | 1,100.00 |
| Jan 1, 2022 | -8,263.00 |
| Oct 2, 2021 | 1,084.00 |
| Jul 3, 2021 | 4,223.00 |
| Apr 3, 2021 | 2,111.00 |